Number of Shares
4,300.00
Current Holdings Value*
円195,500.00
% of Portfolio
5.19%
Total Estimate Gain
円8.70 Mil
% of Total Estimate Gain
33.25%

Amplify Weight Loss Drug & Treatment ETF's Chugai Pharmaceutical Co Ltd Holding Summary

As of 2025-03-31, Amplify Weight Loss Drug & Treatment ETF held 4,300.00 shares of Chugai Pharmaceutical Co Ltd(TSE:4519), totaling 円195,500.00. This investment constitutes 5.19% of their stock portfolio, and Amplify Weight Loss Drug & Treatment ETF now holds 0% of the outstanding Chugai Pharmaceutical Co Ltd(TSE:4519) stock.

The initial trade took place in 2024Q2. And since then Amplify Weight Loss Drug & Treatment ETF has made 2 purchases of TSE:4519, at an average price of 円5,342.57, for a total of 4,900.00 shares. In addition, there have been 1 sales at an average price of 円6,966.64 for 600.00 shares. Based on historical transaction data and TSE:4519's current price of 円7140.00, Amplify Weight Loss Drug & Treatment ETF's estimated gain on his TSE:4519 holdings is 円8.70 Mil, reflecting a 33.25% gain to date.

Amplify Weight Loss Drug & Treatment ETF TSE:4519 (円7140.00) Holding Chart

Amplify Weight Loss Drug & Treatment ETF TSE:4519 (円7140.00) Quarterly Buys and Sells

Period Bought/Sold (Sh.) % Change Qtr. End Shares Avrg. Price
Shares Bought 0 Average Price 円-/Share
Shares Sold 0 Average Price 円-/Share
Current Price 円0.00 Total Estimated Gain 0 %

Top Ranked Articles

  • 1